LONDON BROKER RATINGS: UBS, Barclays cut Rightmove; RBC gives it raise
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 92.30p on 17-11-2025 at 09:14:07 |
|---|---|
| Change | -0.20p -0.22% |
| Buy | 92.30p |
| Sell | 92.10p |
| Last Trade: | Sell 2,270.00 at 92.15p |
| Day's Volume: | 87,285 |
| Last Close: | 92.50p |
| Open: | 92.60p |
| ISIN: | GB00B0744359 |
| Day's Range | 92.00p - 92.90p |
| 52wk Range: | 88.60p - 156.00p |
| Market Capitalisation: | £263.30m |
| VWAP: | 92.35772p |
| Shares in Issue: | 285.27m |
Essentra (ESNT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,270 | 92.15p | Ordinary |
09:14:06 - 17-Nov-25 |
| Buy* | 500 | 92.30p | Automatic Execution |
09:14:04 - 17-Nov-25 |
| Sell* | 39 | 92.10p | Automatic Execution |
09:13:57 - 17-Nov-25 |
| Sell* | 731 | 92.10p | Automatic Execution |
09:13:57 - 17-Nov-25 |
| Sell* | 3,360 | 92.10p | Automatic Execution |
09:13:46 - 17-Nov-25 |
| Sell* | 862 | 92.20p | Automatic Execution |
09:13:46 - 17-Nov-25 |
| Sell* | 642 | 92.20p | Automatic Execution |
09:13:46 - 17-Nov-25 |
| Buy* | 127 | 92.30p | Automatic Execution |
09:13:46 - 17-Nov-25 |
| Sell* | 5,436 | 92.145p | Negotiated Trade |
09:11:45 - 17-Nov-25 |
| Sell* | 40 | 92.20p | Automatic Execution |
09:10:36 - 17-Nov-25 |
Essentra (ESNT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 11th Nov 2025 8:35 am | RNS | Holding(s) in Company |
| 11th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 10th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 6th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 4th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 3rd Nov 2025 7:00 am | RNS | Total Voting Rights |
| 3rd Nov 2025 7:00 am | RNS | Transaction in Own Shares* |
| 30th Oct 2025 7:00 am | RNS | Transaction in Own Shares |
| 30th Oct 2025 7:00 am | RNS | Q3 2025 Trading Update |